Effect of Reminders on Adherence

NCT ID: NCT02411006

Last Updated: 2016-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

47088 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence. The investigators will send mailings to subjects once per month, and elicit responses via mail, phone, and web surveys.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual care control

No intervention, just usual care from the insurance company

Group Type NO_INTERVENTION

No interventions assigned to this group

Reminder control

Send a reminder to subjects every month

Group Type EXPERIMENTAL

Reminder

Intervention Type BEHAVIORAL

Remind people to take their medicine

Anonymous prediction

Ask subjects to anonymously predict their upcoming medication adherence

Group Type EXPERIMENTAL

Prediction mailing

Intervention Type BEHAVIORAL

Ask people to predict their upcoming medication adherence

Reminder

Intervention Type BEHAVIORAL

Remind people to take their medicine

Anonymity

Intervention Type BEHAVIORAL

Keep patient predictions and commitment anonymous

Anonymous commitment

Ask subjects to anonymously commit to their upcoming medication adherence

Group Type EXPERIMENTAL

Commitment mailing

Intervention Type BEHAVIORAL

Ask people to commit to their upcoming medication adherence

Reminder

Intervention Type BEHAVIORAL

Remind people to take their medicine

Anonymity

Intervention Type BEHAVIORAL

Keep patient predictions and commitment anonymous

Identified prediction

Ask subjects to predict their upcoming medication adherence and report it

Group Type EXPERIMENTAL

Prediction mailing

Intervention Type BEHAVIORAL

Ask people to predict their upcoming medication adherence

Reminder

Intervention Type BEHAVIORAL

Remind people to take their medicine

Identification

Intervention Type BEHAVIORAL

Ask patients to report their predictions and commitments

Identified commitment

Ask subjects to commit to their upcoming medication adherence and report it

Group Type EXPERIMENTAL

Commitment mailing

Intervention Type BEHAVIORAL

Ask people to commit to their upcoming medication adherence

Reminder

Intervention Type BEHAVIORAL

Remind people to take their medicine

Identification

Intervention Type BEHAVIORAL

Ask patients to report their predictions and commitments

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prediction mailing

Ask people to predict their upcoming medication adherence

Intervention Type BEHAVIORAL

Commitment mailing

Ask people to commit to their upcoming medication adherence

Intervention Type BEHAVIORAL

Reminder

Remind people to take their medicine

Intervention Type BEHAVIORAL

Anonymity

Keep patient predictions and commitment anonymous

Intervention Type BEHAVIORAL

Identification

Ask patients to report their predictions and commitments

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* customers of the investigators' insurance company partner

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katherine Milkman, Ph.D

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Dai H, Mao D, Volpp KG, Pearce HE, Relish MJ, Lawnicki VF, Milkman KL. The effect of interactive reminders on medication adherence: A randomized trial. Prev Med. 2017 Oct;103:98-102. doi: 10.1016/j.ypmed.2017.07.019. Epub 2017 Jul 24.

Reference Type DERIVED
PMID: 28751176 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H14P001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.